BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9050037)

  • 1. Clinical and therapeutic aspects of renal amyloidosis.
    Schena FP; Pannarale G; Carbonara MC
    Nephrol Dial Transplant; 1996; 11 Suppl 9():63-8. PubMed ID: 9050037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement therapy in end-stage renal amyloidosis.
    Banks RA; Tribe CR; White HJ; Harrison PR; Mackenzie JC
    J R Soc Med; 1985 Jul; 78(7):593-4. PubMed ID: 3892002
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in diagnosis and treatment of AL amyloidosis].
    Zelichowski G; Lubas A; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):340-5. PubMed ID: 18634370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.
    Gertz MA; Kyle RA; O'Fallon WM
    Arch Intern Med; 1992 Nov; 152(11):2245-50. PubMed ID: 1444684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration.
    Dogukan A; Oymak FS; Taskapan H; Güven M; Tokgoz B; Utas C
    Clin Nephrol; 2001 Feb; 55(2):181-2. PubMed ID: 11269688
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
    Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
    Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal amyloidosis in childhood. An overview of the topic with 25 years experience.
    Tinaztepe K
    Turk J Pediatr; 1995; 37(4):357-73. PubMed ID: 8560604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal amyloidosis].
    Cuchard P; Cuchard R; Rotman S; Burnier M; Gauthier T
    Rev Med Suisse; 2012 Feb; 8(330):446-51. PubMed ID: 22452129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and treatment of systemic amyloidosis.
    Gillmore JD; Hawkins PN
    Nat Rev Nephrol; 2013 Oct; 9(10):574-86. PubMed ID: 23979488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal disease in multiple myeloma].
    Hiromura K; Nojima Y
    Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis treatment in children with amyloidosis due to juvenile rheumatoid arthritis.
    Sieniawska M; Roszkowska-Blaim M; Wojciechowska B
    Turk J Pediatr; 1996; 38(1):59-66. PubMed ID: 8819622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal amyloidosis].
    Kościelska M; Shebani Z; Matuszkiewicz-Rowińska J
    Przegl Lek; 2013; 70(4):205-10. PubMed ID: 23991559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary amyloidosis treated with continuous ambulatory peritoneal dialysis.
    Gude D; Chennemsetty S; Jha R; Narayan G
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1285-7. PubMed ID: 23168867
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal involvement in systemic amyloidosis.
    Browning M; Banks R; Tribe C; Bacon P; Hollingworth P; Kingswood C; Poulding J; Harrison P; Mackenzie JC
    Proc Eur Dial Transplant Assoc; 1983; 20():595-602. PubMed ID: 6657678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney and liver involvement in monoclonal light chain disorders.
    Pozzi C; Locatelli F
    Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CAPD treatment in children with renal amyloidosis].
    Wojciechowska B; Ziółkowska H; Warchoł S; Roszkowska-Blaim M
    Pol Merkur Lekarski; 2000 Apr; 8(46):276-7. PubMed ID: 10897648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of renal amyloidosis with chronic hemodialysis].
    Mukharliamova LIu; Vinogradova OM; Ermolenko VM
    Ter Arkh; 1985; 57(6):142-3. PubMed ID: 4071403
    [No Abstract]   [Full Text] [Related]  

  • 20. New advances in renal amyloidosis.
    Nishi S; Alchi B; Imai N; Gejyo F
    Clin Exp Nephrol; 2008 Apr; 12(2):93-101. PubMed ID: 18175051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.